Benzinga's Top #PreMarket Gainers

Furiex Pharmaceuticals

soared 93.85% to $88.88 in the pre-market trading on positive top-line results from two pivotal Phase III clinical trials of eluxadoline for IBS-d. ATMI

shares gained 25.32% to $33.75 in the pre-market after the company reported upbeat Q4 earnings. Entegris

also announced its plans to acquire ATMI. Michael Kors Holdings

shares jumped 19.49% to $91.61 in pre-market trading after the company reported upbeat Q3 earnings and issued strong FY14 outlook. Entegris

surged 6.46% to $11.20 in the pre-market session after the company announced its plans to acquire ATMI for $34 per share.